SCHEMBL7704919

SCHEMBL7704919

CCOC(=O)N1CCN(CCc2ccccc2OCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.54
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
SIGMAR1 Q99720 2/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43
TSHR P16473 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
HTR2A P28223 1/20 0.42
HTR7 P34969 1/20 0.42
OPRM1 P35372 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705823 0.88 TACR1 (0.44) TACR1SIGMAR1L3MBTL1
SCHEMBL7702105 0.87 TACR1 (0.47) TACR1KDM4ESIGMAR1MEN1KMT2A
SCHEMBL7707683 0.84 TACR1 (0.55) TACR1
SCHEMBL7705623 0.84 TACR1 (0.56) TACR1
SCHEMBL7705827 0.83 TACR1 (0.56) TACR1SIGMAR1
SCHEMBL7702017 0.83 ALDH1A1 (0.45) TACR1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7699833 0.83 TACR1 (0.49) TACR1SIGMAR1
SCHEMBL7705390 0.82 TACR1 (0.60) TACR1SIGMAR1
SCHEMBL7699781 0.81 TACR1 (0.61) TACR1ALDH1A1KDM4EKMT2ALMNA
SCHEMBL7699901 0.81 TACR1 (0.59) TACR1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed